Barclays Capital Global Healthcare Conference (Infinity Pharmaceuticals) - Mar 16, 2011 - retaspimycin (IPI504)/ Infinity Pharma; Expected to present P1 data of IPI-504 in combination with docetaxel & to announce future plans for Hsp90 program in 2011
Anticipated development program
|